These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 10520979)

  • 1. Efficacy, safety, and gradual discontinuation of clonazepam in panic disorder: a placebo-controlled, multicenter study using optimized dosages.
    Moroz G; Rosenbaum JF
    J Clin Psychiatry; 1999 Sep; 60(9):604-12. PubMed ID: 10520979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonazepam in the treatment of panic disorder with or without agoraphobia: a dose-response study of efficacy, safety, and discontinuance. Clonazepam Panic Disorder Dose-Response Study Group.
    Rosenbaum JF; Moroz G; Bowden CL
    J Clin Psychopharmacol; 1997 Oct; 17(5):390-400. PubMed ID: 9315990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind clonazepam vs placebo in panic disorder treatment.
    Valença AM; Nardi AE; Nascimento I; Mezzasalma MA; Lopes FL; Zin W
    Arq Neuropsiquiatr; 2000 Dec; 58(4):1025-9. PubMed ID: 11105068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder.
    Ballenger JC; Wheadon DE; Steiner M; Bushnell W; Gergel IP
    Am J Psychiatry; 1998 Jan; 155(1):36-42. PubMed ID: 9433336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychopharmacotherapy of panic disorder: 8-week randomized trial with clonazepam and paroxetine.
    Nardi AE; Valença AM; Freire RC; Mochcovitch MD; Amrein R; Sardinha A; Levitan MN; Nascimento I; de-Melo-Neto VL; King AL; de O E Silva AC; Veras AB; Dias GP; Soares-Filho GL; da Costa RT; Mezzasalma MA; de Carvalho MR; de Cerqueira AC; Hallak JE; Crippa JA; Versiani M
    Braz J Med Biol Res; 2011 Apr; 44(4):366-73. PubMed ID: 21344132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonazepam in the treatment of panic disorder: a double-blind, placebo-controlled trial investigating the correlation between clonazepam concentrations in plasma and clinical response.
    Beauclair L; Fontaine R; Annable L; Holobow N; Chouinard G
    J Clin Psychopharmacol; 1994 Apr; 14(2):111-8. PubMed ID: 8195451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sertraline in the treatment of panic disorder: a double-blind multicenter trial.
    Pohl RB; Wolkow RM; Clary CM
    Am J Psychiatry; 1998 Sep; 155(9):1189-95. PubMed ID: 9734541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adinazolam-SR in panic disorder with agoraphobia: relationship of daily dose to efficacy.
    Carter CS; Fawcett J; Hertzman M; Papp LA; Jones W; Patterson WM; Swinson RP; Weise CC; Maddock RJ; Denahan AQ
    J Clin Psychiatry; 1995 May; 56(5):202-10. PubMed ID: 7737960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
    Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B
    Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic response to benzodiazepine in panic disorder subtypes.
    Valença AM; Nardi AE; Mezzasalma MA; Nascimento I; Zin WA; Lopes FL; Versiani M
    Sao Paulo Med J; 2003 Mar; 121(2):77-80. PubMed ID: 12870055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reboxetine, a selective norepinephrine reuptake inhibitor, is an effective and well-tolerated treatment for panic disorder.
    Versiani M; Cassano G; Perugi G; Benedetti A; Mastalli L; Nardi A; Savino M
    J Clin Psychiatry; 2002 Jan; 63(1):31-7. PubMed ID: 11838623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term experience with clonazepam in patients with a primary diagnosis of panic disorder.
    Worthington JJ; Pollack MH; Otto MW; McLean RY; Moroz G; Rosenbaum JF
    Psychopharmacol Bull; 1998; 34(2):199-205. PubMed ID: 9641001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sertraline treatment of panic disorder: response in patients at risk for poor outcome.
    Pollack MH; Rapaport MH; Clary CM; Mardekian J; Wolkow R
    J Clin Psychiatry; 2000 Dec; 61(12):922-7. PubMed ID: 11206597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind, placebo-controlled study of a once-a-day, sustained-release preparation of alprazolam for the treatment of panic disorder.
    Schweizer E; Patterson W; Rickels K; Rosenthal M
    Am J Psychiatry; 1993 Aug; 150(8):1210-5. PubMed ID: 8328566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tapering clonazepam in patients with panic disorder after at least 3 years of treatment.
    Nardi AE; Freire RC; Valença AM; Amrein R; de Cerqueira AC; Lopes FL; Nascimento I; Mezzasalma MA; Veras AB; Sardinha A; de Carvalho MR; da Costa RT; Levitan MN; de-Melo-Neto VL; Soares-Filho GL; Versiani M
    J Clin Psychopharmacol; 2010 Jun; 30(3):290-3. PubMed ID: 20473065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A controlled, prospective, 1-year trial of citalopram in the treatment of panic disorder.
    Lepola UM; Wade AG; Leinonen EV; Koponen HJ; Frazer J; Sjödin I; Penttinen JT; Pedersen T; Lehto HJ
    J Clin Psychiatry; 1998 Oct; 59(10):528-34. PubMed ID: 9818634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects.
    Pecknold JC; Swinson RP; Kuch K; Lewis CP
    Arch Gen Psychiatry; 1988 May; 45(5):429-36. PubMed ID: 3282479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind, placebo-controlled trial of two doses of abecarnil for geriatric anxiety.
    Small GW; Bystritsky A
    J Clin Psychiatry; 1997; 58 Suppl 11():24-9. PubMed ID: 9363045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discontinuation reactions to alprazolam in panic disorder.
    Pecknold JC
    J Psychiatr Res; 1993; 27 Suppl 1():155-70. PubMed ID: 8145176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome assessment and clinical improvement in panic disorder: evidence from a randomized controlled trial of fluoxetine and placebo. The Fluoxetine Panic Disorder Study Group.
    Michelson D; Lydiard RB; Pollack MH; Tamura RN; Hoog SL; Tepner R; Demitrack MA; Tollefson GD
    Am J Psychiatry; 1998 Nov; 155(11):1570-7. PubMed ID: 9812120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.